Pharma & Biotech Stock Review & Outlook

Pharma & Biotech Stock Review & Outlook – Industry Outlook

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on December 28, 2011 at 13:33 PM EST

With 2011 coming to an end, the pharmaceutical industry continues to face challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition, pipeline failures and limited late-stage catalysts.

Related Stocks:

Abbott Laboratories Bristol-Myers Squibb Co. Celgene Corp Dentsply International, Inc. Eli Lilly & Co. GlaxoSmithKline PLC ADS Johnson & Johnson Merck & Co., Inc. Pfizer, Inc. Vertex Pharmaceuticals, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates